Education
About Us
Working with TipRanks
Follow Us
Inspire Medical Systems (INSP)
NYSE:INSP
INSP Stock Chart & Stats
$86.35
-$1.46(-0.68%)
At close: 4:00 PM EST
$86.35
-$1.46(-0.68%)
Day’s Range― - ―
52-Week Range$70.77 - $216.01
Previous CloseN/A
Volume95.34K
Average Volume (3M)1.17M
Market Cap
$2.51B
Enterprise Value$1.91B
Total Cash (Recent Filing)$322.59M
Total Debt (Recent Filing)$32.58M
Price to Earnings (P/E)59.2
Beta0.26
Next Earnings
Feb 10, 2026EPS Estimate
0.67Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.38
Shares Outstanding29,056,435
10 Day Avg. Volume1,618,420
30 Day Avg. Volume1,173,880
Financial Highlights & Ratios
PEG Ratio-0.29
Price to Book (P/B)8.00
Price to Sales (P/S)6.87
P/FCF Ratio60.55
Enterprise Value/Market Cap0.76
Enterprise Value/Revenue2.16
Enterprise Value/Gross Profit2.54
Enterprise Value/Ebitda24.88
Forecast
1Y Price Target
$105.50Price Target Upside22.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)0.99
Revenue Forecast (FY)$903.84M
Bulls Say, Bears Say
Bulls Say
Market OpportunityAn attractive opportunity to buy a clinically differentiated company serving unmet need in a less than 5% penetrated market with an impressive growth outlook.
Market ShareMarket penetration remains low, and Inspire Medical is expected to continue increasing its market share driven by favorable market trends.
ValuationThe stock is trading at significantly lower multiples compared to its peers, suggesting it may be undervalued.
Bears Say
Competitive PressureIncoming HGNS competition could limit INSP's ability to accelerate sales growth, with potential market share declines expected.
Market DisruptionSurvey results indicate a significant percentage of doctors believe GLP-1s could negatively impact long-term growth in the HGNS market.
Reimbursement ChallengesLower doctor fee reimbursement for Inspire 5 is expected to limit volume benefits and new surgeon adoption.
Inspire Medical Systems News
INSP FAQ
What was Inspire Medical Systems’s price range in the past 12 months?
Inspire Medical Systems lowest stock price was $70.77 and its highest was $216.01 in the past 12 months.
What is Inspire Medical Systems’s market cap?
Inspire Medical Systems’s market cap is $2.51B.
When is Inspire Medical Systems’s upcoming earnings report date?
Inspire Medical Systems’s upcoming earnings report date is Feb 10, 2026 which is in 85 days.
How were Inspire Medical Systems’s earnings last quarter?
Inspire Medical Systems released its earnings results on Nov 03, 2025. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of -$0.189 by $0.569.
Is Inspire Medical Systems overvalued?
According to Wall Street analysts Inspire Medical Systems’s price is currently Undervalued.
Does Inspire Medical Systems pay dividends?
Inspire Medical Systems does not currently pay dividends.
What is Inspire Medical Systems’s EPS estimate?
Inspire Medical Systems’s EPS estimate is 0.67.
How many shares outstanding does Inspire Medical Systems have?
Inspire Medical Systems has 29,056,435 shares outstanding.
What happened to Inspire Medical Systems’s price movement after its last earnings report?
Inspire Medical Systems reported an EPS of $0.38 in its last earnings report, beating expectations of -$0.189. Following the earnings report the stock price went up 15.33%.
Which hedge fund is a major shareholder of Inspire Medical Systems?
Currently, no hedge funds are holding shares in INSP
Inspire Medical Systems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$105.50 (22.18% Upside)
$105.50 (22.18% Upside)
Blogger Sentiment
Bullish
INSP Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 66.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.4%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-50.06%
12-Months-Change
Fundamentals
Return on Equity
6.54%
Trailing 12-Months
Asset Growth
1.45%
Trailing 12-Months
Company Description
Inspire Medical Systems
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
INSP Company Deck
INSP Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and improved gross margins, driven by the successful launch and adoption of Inspire V and positive clinical outcomes. However, these positives were somewhat offset by increased operating expenses and decreased net income compared to the prior year. The company remains optimistic with increased earnings guidance and improved reimbursement outlook.View all INSP earnings summariesINSP Revenue Breakdown
97.02% U.S.
2.98% Other
INSP Stock 12 Month Forecast
Average Price Target
$105.50
▲(22.18% Upside)
Technical Analysis
Integer Holdings
―
LivaNova
―
Irhythm Technologies
―
TransMedics Group
―
PROCEPT BioRobotics
―
Ownership Overview
1.02% Insiders
42.24% Mutual Funds
0.55% Other Institutional Investors
32.37% Public Companies and Individual Investors